The potential reason why is fascinating.

The large-scale study is one of the first to evaluate the two-dose recombinant zoster vaccine (Shingrix) in a large sample group. Previous research has shown that dementia risk is lower with the ...

Dynavax Technologies Corporation (NASDAQ:DVAX) announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial of Z-1018, a shingles vaccine ...

Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. (CNN) — Although the two-dose ...

While lifesaving vaccines face a relentless onslaught from the Trump administration—with fervent anti-vaccine advocate Robert F. Kennedy Jr. leading the charge—scientific literature is building a ...